Martin Griesshammer
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 17, 2025
Response to the commentary by Xu et al. on the PV-AIM study.Florian H Heidel, Martin Griesshammer, Jean-Jacques Kiladjian
|Apr 25, 2025
Prediction of resistance to hydroxyurea therapy in patients with polycythemia vera: a machine learning study (PV-AIM) validated in a prospective interventional phase IV trial (HU-F-AIM).Florian H Heidel, Valerio De Stefano, Matthias Zaiss
|Feb 05, 2020
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.Haifa Kathrin Al-Ali, Martin Griesshammer, Lynda Foltz
|Mar 09, 2019
Thromboembolic events in polycythemia vera.Martin Griesshammer, Jean-Jacques Kiladjian, Carlos Besses
Pageof 1
